Last update 21 Nov 2024

Zevorcabtagene Autoleucel

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
Anti-BCMA CAR T cell therapy, BCMA-redirected autologous T cells-CARsgen, CAR BCMA T-cell therapy-CARsgen
+ [10]
Target
Mechanism
BCMA modulators(B-cell maturation protein modulators)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (23 Feb 2024),
RegulationPRIME (EU), Conditional marketing approval (CN), Orphan Drug (EU), Breakthrough Therapy (CN), Priority Review (CN), Regenerative Medicine Advanced Therapy (US)
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Multiple Myeloma
CN
23 Feb 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPhase 2
CA
25 Sep 2019
Multiple MyelomaPhase 2
US
25 Sep 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
102
(nagrmmdyiz) = zbypprfjtk aucuogqmoe (calqjkxlfs, 85.13 - 96.55)
Positive
09 Dec 2024
(nagrmmdyiz) = qrvvxgwzah aucuogqmoe (calqjkxlfs )
Phase 2
102
(ugdohnbbab) = lvarhhzxxb peynpyhwdu (zwciqaokyp, 85.13 - 96.55)
Positive
14 May 2024
Phase 1
14
(grmcgqfjlh) = hlqzyevqvd vtomhhoxcl (lyqmqxlgzr )
-
11 Dec 2023
(grmcgqfjlh) = kzmczwrnto vtomhhoxcl (lyqmqxlgzr )
Phase 2
102
(awgcibwvzt) = nzxtfhiyah spnkjppkqx (jitenbjgan )
Positive
15 Nov 2022
Phase 2
17
Fludarabine Phosphate+Cyclophosphamide+Zevorcabtagene autoleucel
(ehmyjolqaa) = abksezyasm dfznafzkyb (kwzsglbaah )
Positive
21 Sep 2022
Phase 1
24
jatpbkyohj(danzghpjqv) = uanrfrbpcx graetzegba (mqggnsivqj )
Positive
06 Dec 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free